Organization: Innovatech Grand Montréal

URRMA shareholders invest additional $2 million

Shareholders in URRMA Biopharma have exercised their options for an additional investment of $2 million in the Montreal-based developer of products to diagnose and treat HIV infection. Franc-Or Corp invested $1 million while Innovatech Grand Montréal and Dacha Capital invested $500,000 each. Franc-Or now holds a 26% interest in URRMA. The new funding is for…

Canacure receives $2-million private placement

Innovatech Grand Montréal is providing $700,000 of a $2-million private placement in Montreal’s Canacure Corp to conduct further R&D for nutraceutical products to optimize the human gastro-intestinal system. Canacure is developing a process that could see it grab a significant piece of the global market which is expected to grow from $60 billion this year…

Minacom secures third private placement

Minacom Inc, Montreal, has secured US$6 million private placement for its third round of financing to further develop and market its quality of service (QoS) management automation software. Innovatech Grand Montréal and Sofinov (a subsidiary of Caisse de dépot et placement du Québec) are the co-lead investors in the financing, followed by Investissement Desjardins and…